Ceftobiprole medocaril
Ceftobiprole medocaril is a prodrug that is converted in vivo to the active cephalosporin, ceftobiprole. This broad-spectrum antibiotic demonstrates potent activity against methicillin-resistant Staphylococcus aureus (MRSA) and is utilized in research involving both in vitro susceptibility testing and in vivo efficacy models for resistant bacterial infections.
Product Specifications
CAS Number
376653-43-9
Product Name Alternative
Gram-negative, gram-positive, MRSA, Inhibitor, inhibit, methicillin, pathogens, Bacterial, BAL 5788, BAL5788, BAL-5788, Antibacterial, Ceftobiprole medocaril, cephalosporin, staphylococci, Prodrug, penicillin, pyrrolidinone, VRSA, vancomycin
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
95.14% (May vary between batches)
Smiles
C (O) (=O) C=1N2[C@@] ([C@H] (NC (/C (=N\O) /C=3N=C (N) SN3) =O) C2=O) (SCC1/C=C\4/C (=O) N (CC4) [C@H]5CN (C (OCC=6OC (=O) OC6C) =O) CC5) [H]
Molecular Formula
C26H26N8O11S2
Molecular Weight
690.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042670-100 1x 100 µL
CD117 / c-Kit (Marker for Gastrointestinal Stromal Tumors) (KIT/2670), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
